跳至主要内容
临床试验/NCT06699615
NCT06699615Enrolling By Invitation不适用

Survey of Medical Oncologists to Assess Trustworthiness of Various Approaches to AI Explainability for Prognostic Models

Abramson Cancer Center at Penn Medicine1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年12月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
50
试验地点
1
主要终点
Determine whether neurosymbolic AI explainability methods improve the trustworthiness of explanations from a prognostic model, relative to post-hoc explainers.

研究概览

简要总结

The objective of this proposal is to conduct a vignette-based survey among practicing oncology clinicians who treat non-small cell lung cancer to assess the trustworthiness of explainable predictions from a neurosymbolic AI vs. State-of-the-art post-hoc explanatory algorithms, using simulated patient data.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • "Medical oncologist" or "Hematologist/Oncologist" designation at Penn Treats lung cancer

排除标准

  • Non-medical oncologists No email address or physical address listed Does not treat lung cancer

研究组 & 干预措施

One time de-identified Qualtrics Survey

Other

干预措施: Once time de-identified Qualtrics survey (Other)

结局指标

主要结局

Determine whether neurosymbolic AI explainability methods improve the trustworthiness of explanations from a prognostic model, relative to post-hoc explainers.

时间窗: 3 months

Oncologist will be invited to complete a vignette-based survey

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验